State Street’s Tenon Medical TNON Stock Holding History

State Street’s Portfolio TNON Stock Details TNON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$1.85K	–	4488
2023 Q3	$1.85K	Hold	4	–	–	﹤0.01%	4551
2023 Q2	$3.27K	Sell	4 -16	-80%	-$58.8K	﹤0.01%	4667
2023 Q1	$101K	Hold	20	–	–	﹤0.01%	4324
2022 Q4	$86.9K	Buy	20 +8	+67%	+$40.8K	﹤0.01%	4411
2022 Q3	$42K	Buy	+12	New	+$70K	﹤0.01%	4690

Other funds holding TNON

TWM

TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $360M AUM 19.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street's TNON Position: Q4 2023 in Review

State Street sold out of Tenon Medical (TNON) in Q4 2023, closing a stake of 4 shares — an estimated $1.85K sold.

State Street first reported a position in TNON in Q3 2022 and held it in 5 quarters. The position peaked at $101K in Q1 2023. 7 funds tracked by Wall St. Rank hold TNON as of Q4 2023.

State Street reported no remaining Tenon Medical position as of Q4 2023 after selling out during the quarter.
State Street sold 4 Tenon Medical shares in Q4 2023, an estimated $1.85K.
State Street first reported a position in Tenon Medical in Q3 2022 and held it in 5 quarters.
State Street's Tenon Medical position peaked at $101K in Q1 2023.
7 funds tracked by Wall St. Rank held Tenon Medical as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.